SCHEMBL24929104

SCHEMBL24929104

Nc1cc(-c2ccns2)c(F)cc1OC1CCCC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 10/20 0.38
ALOX5AP P20292 8/20 0.38
MCHR1 Q99705 2/20 0.35
CHEK1 O14757 1/20 0.32
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
CCNA1 P78396 1/20 0.32
CSNK2A1 P68400 2/20 0.32
PDE4A P27815 2/20 0.31
F2 P00734 1/20 0.31
F10 P00742 1/20 0.31
PLG P00747 1/20 0.31
PLAU P00749 1/20 0.31
PLAT P00750 1/20 0.31
LOX P28300 1/20 0.31
LOXL2 Q9Y4K0 1/20 0.31
EIF4E P06730 1/20 0.31
MKNK1 Q9BUB5 1/20 0.31
MKNK2 Q9HBH9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24930069 0.85 CSNK2A1 (0.39) MCHR1CHEK1CCNA2CDK2CCNA1
SCHEMBL24928863 0.82 CSNK2A1 (0.36) MCHR1CHEK1CCNA2CDK2CCNA1
SCHEMBL30845564 0.82 CYP19A1 (0.35) FEN1ALOX5APPLAT
SCHEMBL24928670 0.78 PDE4A (0.38) MCHR1CSNK2A1PDE4AMKNK1MKNK2
SCHEMBL24928930 0.72
SCHEMBL19643299 0.71 CSNK2A1 (0.36) FEN1ALOX5APMCHR1CSNK2A1PDE4A
SCHEMBL24929568 0.69 BRD4 (0.33) FEN1ALOX5AP
SCHEMBL30845559 0.68 BCL6 (0.37) CSNK2A1
SCHEMBL24928929 0.68 CSNK2A1 (0.34) CSNK2A1PDE4A
SCHEMBL22637224 0.66 ALDH1A1 (0.38) CHEK1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117881657-A Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1 modulators 格雷沃尔夫治疗有限公司 2024-04-12 CN disclosed
WO-2023007188-A1 PHENYL-SULFAMOYL-BENZOIC ACID DERIVATIVES AS ERAP1- MODULATORS Grey Wolf Therapeutics Limited (GB) 2023-02-02 WO disclosed